Aton Ra Partners Abiomed Inc Transaction History

Aton Ra Partners

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $233,517 - $290,305	-963 Reduced 16.7%	4,803 $1.18 Million
Q2 2022 Aug 15, 2022	SELL	$224.73 - $338.64 $624,524 - $941,080	-2,779 Reduced 32.52%	5,766 $1.43 Million
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $877,496 - $1.16 Million	-3,165 Reduced 27.03%	8,545 $2.83 Million
Q4 2021 Feb 14, 2022	BUY	$300.63 - $371.35 $55,616 - $68,699	185 Added 1.61%	11,710 $4.21 Million
Q3 2021 Nov 15, 2021	BUY	$310.19 - $376.2 $405,108 - $491,317	1,306 Added 12.78%	11,525 $3.75 Million
Q2 2021 Aug 12, 2021	SELL	$262.71 - $351.17 $89,321 - $119,397	-340 Reduced 3.22%	10,219 $3.19 Million
Q1 2021 May 17, 2021	SELL	$285.92 - $355.13 $759,403 - $943,225	-2,656 Reduced 20.1%	10,559 $3.37 Million
Q4 2020 Feb 19, 2021	BUY	$251.88 - $324.2 $3.33 Million - $4.28 Million	13,215 New	13,215 $4.28 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

Stay updated on Aton Ra Partners with notifications on news.